Mitogen-activated Protein Kinase Inhibitors Induce Apoptosis and Enhance the Diallyl Disulfide-induced Apoptotic Effect in Human CNE2 Cells
Authors:
- 1 January 2008
- journal article
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 54 (2) , 129-136
Abstract
In this study, we investigated whether the inhibition of endogenous phosphorylation of mitogen-activated protein kinase (MAPK) and diallyl disulfide (DADS)-induced phosphorylation of MAPKs with MAPK specific inhibitors, SB203580 and U0126 (for phospho-p38 and phospho-p42/p44, respectively), can induce or enhance apoptosis in human CNE2 nasopharyngeal carcinoma cells. Our data demonstrate that MAPK inhibitors decrease the viability of CNE2 cells, stimulate typical apoptotic morphologic changes, and enhance DADS-induced apoptosis. The present findings indicate that phosphorylation of MAPKs plays an important cytoprotective role in CNE2 cell apoptosis and the DADS-induced apoptotic process.Keywords
This publication has 50 references indexed in Scilit:
- Diallyl Disulfide and Diallyl Trisulfide Up-Regulate the Expression of the π Class of Glutathione S-Transferase via an AP-1-Dependent PathwayJournal of Agricultural and Food Chemistry, 2007
- Diallyl Disulfide Increases CDKN1A Promoter-Associated Histone Acetylation in Human Colon Tumor Cell LinesJournal of Agricultural and Food Chemistry, 2006
- Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cellsBiochemical Pharmacology, 2004
- Basic fibroblast growth factor protects cardiac myocytes from iNOS‐mediated apoptosisJournal of Cellular Physiology, 2001
- Transforming Growth Factor β1 (TGF-β1) Promotes Endothelial Cell Survival during In Vitro Angiogenesis via an Autocrine Mechanism Implicating TGF-α SignalingMolecular and Cellular Biology, 2001
- Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell LinesMolecular Pharmacology, 2001
- Microtubule Inhibitors Elicit Differential Effects on MAP Kinase (JNK, ERK, and p38) Signaling Pathways in Human KB-3 Carcinoma CellsExperimental Cell Research, 2000
- MEK Kinase 1 (MEKK1) Transduces c-Jun NH2-terminal Kinase Activation in Response to Changes in the Microtubule CytoskeletonJournal of Biological Chemistry, 1999
- Microtubule Dysfunction Induced by Paclitaxel Initiates Apoptosis through Both c-Jun N-terminal Kinase (JNK)-dependent and -Independent Pathways in Ovarian Cancer CellsJournal of Biological Chemistry, 1999
- The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ RadiationJournal of Biological Chemistry, 1996